Astria Therapeutics

Catabasis, headquartered in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company focused on treating inflammatory and metabolic diseases with drugs. Their platform technology enables the discovery and development of small molecules that simultaneously and specifically target inflammatory pathways.On September 8, 2021, Catabasis Pharmaceuticals, Inc. officially announced its name change to Astria Therapeutics, Inc., with the stock trading symbol changing to "ATXS."